At the molecular level, it has been observed that IDTCs display exacerbated expression of drug efflux ATB-binding cassette transporters and melanoma stem cell markers and loss of differentiation markers such as melan-A and Tyrosinase, which are MITF-target genes. The gene discussed is MITF; the disease is melanoma.